COVID-19 Impact on Global Dihydroartemisinin, Market Insights and Forecast to 2026
Dihydroartemisinin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dihydroartemisinin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dihydroartemisinin market is segmented into
The Dihydroartemisinin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dihydroartemisinin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dihydroartemisinin Market Share Analysis
Dihydroartemisinin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dihydroartemisinin business, the date to enter into the Dihydroartemisinin market, Dihydroartemisinin product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Dihydroartemisinin market is segmented into
- Pharmaceutical Grade
- Industrial Grade
- Malaria Treatment
- Scientific Research
- Others
The Dihydroartemisinin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dihydroartemisinin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dihydroartemisinin Market Share Analysis
Dihydroartemisinin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dihydroartemisinin business, the date to enter into the Dihydroartemisinin market, Dihydroartemisinin product introduction, recent developments, etc.
The major vendors covered:
- Sanofi
- KPC Pharmaceuticals
- Guangxi Xiancaotang Pharmaceutical
- Guilin Pharmaceutical
- Kerui Nanhai Pharmaceutical
- Shanghai Natural Bio-engineering Co
- Novanat Bioresource
- Botanical Extracts EPZ Ltd
1 STUDY COVERAGE
1.1 Dihydroartemisinin Product Introduction
1.2 Market Segments
1.3 Key Dihydroartemisinin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dihydroartemisinin Market Size Growth Rate by Type
1.4.2 Pharmaceutical Grade
1.4.3 Industrial Grade
1.5 Market by Application
1.5.1 Global Dihydroartemisinin Market Size Growth Rate by Application
1.5.2 Malaria Treatment
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Dihydroartemisinin Industry Impact
1.6.1 How the Covid-19 is Affecting the Dihydroartemisinin Industry
1.6.1.1 Dihydroartemisinin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Dihydroartemisinin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Dihydroartemisinin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Dihydroartemisinin Market Size Estimates and Forecasts
2.1.1 Global Dihydroartemisinin Revenue 2015-2026
2.1.2 Global Dihydroartemisinin Sales 2015-2026
2.2 Dihydroartemisinin Market Size by Region: 2020 Versus 2026
2.2.1 Global Dihydroartemisinin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dihydroartemisinin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DIHYDROARTEMISININ COMPETITOR LANDSCAPE BY PLAYERS
3.1 Dihydroartemisinin Sales by Manufacturers
3.1.1 Dihydroartemisinin Sales by Manufacturers (2015-2020)
3.1.2 Dihydroartemisinin Sales Market Share by Manufacturers (2015-2020)
3.2 Dihydroartemisinin Revenue by Manufacturers
3.2.1 Dihydroartemisinin Revenue by Manufacturers (2015-2020)
3.2.2 Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dihydroartemisinin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2019
3.2.5 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dihydroartemisinin Price by Manufacturers
3.4 Dihydroartemisinin Manufacturing Base Distribution, Product Types
3.4.1 Dihydroartemisinin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dihydroartemisinin Product Type
3.4.3 Date of International Manufacturers Enter into Dihydroartemisinin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Dihydroartemisinin Market Size by Type (2015-2020)
4.1.1 Global Dihydroartemisinin Sales by Type (2015-2020)
4.1.2 Global Dihydroartemisinin Revenue by Type (2015-2020)
4.1.3 Dihydroartemisinin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dihydroartemisinin Market Size Forecast by Type (2021-2026)
4.2.1 Global Dihydroartemisinin Sales Forecast by Type (2021-2026)
4.2.2 Global Dihydroartemisinin Revenue Forecast by Type (2021-2026)
4.2.3 Dihydroartemisinin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dihydroartemisinin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Dihydroartemisinin Market Size by Application (2015-2020)
5.1.1 Global Dihydroartemisinin Sales by Application (2015-2020)
5.1.2 Global Dihydroartemisinin Revenue by Application (2015-2020)
5.1.3 Dihydroartemisinin Price by Application (2015-2020)
5.2 Dihydroartemisinin Market Size Forecast by Application (2021-2026)
5.2.1 Global Dihydroartemisinin Sales Forecast by Application (2021-2026)
5.2.2 Global Dihydroartemisinin Revenue Forecast by Application (2021-2026)
5.2.3 Global Dihydroartemisinin Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Dihydroartemisinin by Country
6.1.1 North America Dihydroartemisinin Sales by Country
6.1.2 North America Dihydroartemisinin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dihydroartemisinin Market Facts & Figures by Type
6.3 North America Dihydroartemisinin Market Facts & Figures by Application
7 EUROPE
7.1 Europe Dihydroartemisinin by Country
7.1.1 Europe Dihydroartemisinin Sales by Country
7.1.2 Europe Dihydroartemisinin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dihydroartemisinin Market Facts & Figures by Type
7.3 Europe Dihydroartemisinin Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Dihydroartemisinin by Region
8.1.1 Asia Pacific Dihydroartemisinin Sales by Region
8.1.2 Asia Pacific Dihydroartemisinin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dihydroartemisinin Market Facts & Figures by Type
8.3 Asia Pacific Dihydroartemisinin Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Dihydroartemisinin by Country
9.1.1 Latin America Dihydroartemisinin Sales by Country
9.1.2 Latin America Dihydroartemisinin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dihydroartemisinin Market Facts & Figures by Type
9.3 Central & South America Dihydroartemisinin Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Dihydroartemisinin by Country
10.1.1 Middle East and Africa Dihydroartemisinin Sales by Country
10.1.2 Middle East and Africa Dihydroartemisinin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Type
10.3 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Dihydroartemisinin Products Offered
11.1.5 Sanofi Recent Development
11.2 KPC Pharmaceuticals
11.2.1 KPC Pharmaceuticals Corporation Information
11.2.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
11.2.5 KPC Pharmaceuticals Recent Development
11.3 Guangxi Xiancaotang Pharmaceutical
11.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
11.3.2 Guangxi Xiancaotang Pharmaceutical Description, Business Overview and Total Revenue
11.3.3 Guangxi Xiancaotang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
11.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
11.4 Guilin Pharmaceutical
11.4.1 Guilin Pharmaceutical Corporation Information
11.4.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
11.4.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
11.4.5 Guilin Pharmaceutical Recent Development
11.5 Kerui Nanhai Pharmaceutical
11.5.1 Kerui Nanhai Pharmaceutical Corporation Information
11.5.2 Kerui Nanhai Pharmaceutical Description, Business Overview and Total Revenue
11.5.3 Kerui Nanhai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
11.5.5 Kerui Nanhai Pharmaceutical Recent Development
11.6 Shanghai Natural Bio-engineering Co
11.6.1 Shanghai Natural Bio-engineering Co Corporation Information
11.6.2 Shanghai Natural Bio-engineering Co Description, Business Overview and Total Revenue
11.6.3 Shanghai Natural Bio-engineering Co Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
11.6.5 Shanghai Natural Bio-engineering Co Recent Development
11.7 Novanat Bioresource
11.7.1 Novanat Bioresource Corporation Information
11.7.2 Novanat Bioresource Description, Business Overview and Total Revenue
11.7.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
11.7.5 Novanat Bioresource Recent Development
11.8 Botanical Extracts EPZ Ltd
11.8.1 Botanical Extracts EPZ Ltd Corporation Information
11.8.2 Botanical Extracts EPZ Ltd Description, Business Overview and Total Revenue
11.8.3 Botanical Extracts EPZ Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
11.8.5 Botanical Extracts EPZ Ltd Recent Development
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Dihydroartemisinin Products Offered
11.1.5 Sanofi Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Dihydroartemisinin Market Estimates and Projections by Region
12.1.1 Global Dihydroartemisinin Sales Forecast by Regions 2021-2026
12.1.2 Global Dihydroartemisinin Revenue Forecast by Regions 2021-2026
12.2 North America Dihydroartemisinin Market Size Forecast (2021-2026)
12.2.1 North America: Dihydroartemisinin Sales Forecast (2021-2026)
12.2.2 North America: Dihydroartemisinin Revenue Forecast (2021-2026)
12.2.3 North America: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
12.3 Europe Dihydroartemisinin Market Size Forecast (2021-2026)
12.3.1 Europe: Dihydroartemisinin Sales Forecast (2021-2026)
12.3.2 Europe: Dihydroartemisinin Revenue Forecast (2021-2026)
12.3.3 Europe: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dihydroartemisinin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dihydroartemisinin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dihydroartemisinin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dihydroartemisinin Market Size Forecast by Region (2021-2026)
12.5 Latin America Dihydroartemisinin Market Size Forecast (2021-2026)
12.5.1 Latin America: Dihydroartemisinin Sales Forecast (2021-2026)
12.5.2 Latin America: Dihydroartemisinin Revenue Forecast (2021-2026)
12.5.3 Latin America: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dihydroartemisinin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dihydroartemisinin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dihydroartemisinin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dihydroartemisinin Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Dihydroartemisinin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Dihydroartemisinin Product Introduction
1.2 Market Segments
1.3 Key Dihydroartemisinin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dihydroartemisinin Market Size Growth Rate by Type
1.4.2 Pharmaceutical Grade
1.4.3 Industrial Grade
1.5 Market by Application
1.5.1 Global Dihydroartemisinin Market Size Growth Rate by Application
1.5.2 Malaria Treatment
1.5.3 Scientific Research
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Dihydroartemisinin Industry Impact
1.6.1 How the Covid-19 is Affecting the Dihydroartemisinin Industry
1.6.1.1 Dihydroartemisinin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Dihydroartemisinin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Dihydroartemisinin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Dihydroartemisinin Market Size Estimates and Forecasts
2.1.1 Global Dihydroartemisinin Revenue 2015-2026
2.1.2 Global Dihydroartemisinin Sales 2015-2026
2.2 Dihydroartemisinin Market Size by Region: 2020 Versus 2026
2.2.1 Global Dihydroartemisinin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dihydroartemisinin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DIHYDROARTEMISININ COMPETITOR LANDSCAPE BY PLAYERS
3.1 Dihydroartemisinin Sales by Manufacturers
3.1.1 Dihydroartemisinin Sales by Manufacturers (2015-2020)
3.1.2 Dihydroartemisinin Sales Market Share by Manufacturers (2015-2020)
3.2 Dihydroartemisinin Revenue by Manufacturers
3.2.1 Dihydroartemisinin Revenue by Manufacturers (2015-2020)
3.2.2 Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dihydroartemisinin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2019
3.2.5 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dihydroartemisinin Price by Manufacturers
3.4 Dihydroartemisinin Manufacturing Base Distribution, Product Types
3.4.1 Dihydroartemisinin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dihydroartemisinin Product Type
3.4.3 Date of International Manufacturers Enter into Dihydroartemisinin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Dihydroartemisinin Market Size by Type (2015-2020)
4.1.1 Global Dihydroartemisinin Sales by Type (2015-2020)
4.1.2 Global Dihydroartemisinin Revenue by Type (2015-2020)
4.1.3 Dihydroartemisinin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dihydroartemisinin Market Size Forecast by Type (2021-2026)
4.2.1 Global Dihydroartemisinin Sales Forecast by Type (2021-2026)
4.2.2 Global Dihydroartemisinin Revenue Forecast by Type (2021-2026)
4.2.3 Dihydroartemisinin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dihydroartemisinin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Dihydroartemisinin Market Size by Application (2015-2020)
5.1.1 Global Dihydroartemisinin Sales by Application (2015-2020)
5.1.2 Global Dihydroartemisinin Revenue by Application (2015-2020)
5.1.3 Dihydroartemisinin Price by Application (2015-2020)
5.2 Dihydroartemisinin Market Size Forecast by Application (2021-2026)
5.2.1 Global Dihydroartemisinin Sales Forecast by Application (2021-2026)
5.2.2 Global Dihydroartemisinin Revenue Forecast by Application (2021-2026)
5.2.3 Global Dihydroartemisinin Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Dihydroartemisinin by Country
6.1.1 North America Dihydroartemisinin Sales by Country
6.1.2 North America Dihydroartemisinin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dihydroartemisinin Market Facts & Figures by Type
6.3 North America Dihydroartemisinin Market Facts & Figures by Application
7 EUROPE
7.1 Europe Dihydroartemisinin by Country
7.1.1 Europe Dihydroartemisinin Sales by Country
7.1.2 Europe Dihydroartemisinin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dihydroartemisinin Market Facts & Figures by Type
7.3 Europe Dihydroartemisinin Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Dihydroartemisinin by Region
8.1.1 Asia Pacific Dihydroartemisinin Sales by Region
8.1.2 Asia Pacific Dihydroartemisinin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dihydroartemisinin Market Facts & Figures by Type
8.3 Asia Pacific Dihydroartemisinin Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Dihydroartemisinin by Country
9.1.1 Latin America Dihydroartemisinin Sales by Country
9.1.2 Latin America Dihydroartemisinin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dihydroartemisinin Market Facts & Figures by Type
9.3 Central & South America Dihydroartemisinin Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Dihydroartemisinin by Country
10.1.1 Middle East and Africa Dihydroartemisinin Sales by Country
10.1.2 Middle East and Africa Dihydroartemisinin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Type
10.3 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Dihydroartemisinin Products Offered
11.1.5 Sanofi Recent Development
11.2 KPC Pharmaceuticals
11.2.1 KPC Pharmaceuticals Corporation Information
11.2.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
11.2.5 KPC Pharmaceuticals Recent Development
11.3 Guangxi Xiancaotang Pharmaceutical
11.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
11.3.2 Guangxi Xiancaotang Pharmaceutical Description, Business Overview and Total Revenue
11.3.3 Guangxi Xiancaotang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
11.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
11.4 Guilin Pharmaceutical
11.4.1 Guilin Pharmaceutical Corporation Information
11.4.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
11.4.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
11.4.5 Guilin Pharmaceutical Recent Development
11.5 Kerui Nanhai Pharmaceutical
11.5.1 Kerui Nanhai Pharmaceutical Corporation Information
11.5.2 Kerui Nanhai Pharmaceutical Description, Business Overview and Total Revenue
11.5.3 Kerui Nanhai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
11.5.5 Kerui Nanhai Pharmaceutical Recent Development
11.6 Shanghai Natural Bio-engineering Co
11.6.1 Shanghai Natural Bio-engineering Co Corporation Information
11.6.2 Shanghai Natural Bio-engineering Co Description, Business Overview and Total Revenue
11.6.3 Shanghai Natural Bio-engineering Co Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
11.6.5 Shanghai Natural Bio-engineering Co Recent Development
11.7 Novanat Bioresource
11.7.1 Novanat Bioresource Corporation Information
11.7.2 Novanat Bioresource Description, Business Overview and Total Revenue
11.7.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
11.7.5 Novanat Bioresource Recent Development
11.8 Botanical Extracts EPZ Ltd
11.8.1 Botanical Extracts EPZ Ltd Corporation Information
11.8.2 Botanical Extracts EPZ Ltd Description, Business Overview and Total Revenue
11.8.3 Botanical Extracts EPZ Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
11.8.5 Botanical Extracts EPZ Ltd Recent Development
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Dihydroartemisinin Products Offered
11.1.5 Sanofi Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Dihydroartemisinin Market Estimates and Projections by Region
12.1.1 Global Dihydroartemisinin Sales Forecast by Regions 2021-2026
12.1.2 Global Dihydroartemisinin Revenue Forecast by Regions 2021-2026
12.2 North America Dihydroartemisinin Market Size Forecast (2021-2026)
12.2.1 North America: Dihydroartemisinin Sales Forecast (2021-2026)
12.2.2 North America: Dihydroartemisinin Revenue Forecast (2021-2026)
12.2.3 North America: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
12.3 Europe Dihydroartemisinin Market Size Forecast (2021-2026)
12.3.1 Europe: Dihydroartemisinin Sales Forecast (2021-2026)
12.3.2 Europe: Dihydroartemisinin Revenue Forecast (2021-2026)
12.3.3 Europe: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dihydroartemisinin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dihydroartemisinin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dihydroartemisinin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dihydroartemisinin Market Size Forecast by Region (2021-2026)
12.5 Latin America Dihydroartemisinin Market Size Forecast (2021-2026)
12.5.1 Latin America: Dihydroartemisinin Sales Forecast (2021-2026)
12.5.2 Latin America: Dihydroartemisinin Revenue Forecast (2021-2026)
12.5.3 Latin America: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dihydroartemisinin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dihydroartemisinin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dihydroartemisinin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dihydroartemisinin Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Dihydroartemisinin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Dihydroartemisinin Market Segments
Table 2. Ranking of Global Top Dihydroartemisinin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dihydroartemisinin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pharmaceutical Grade
Table 5. Major Manufacturers of Industrial Grade
Table 6. COVID-19 Impact Global Market: (Four Dihydroartemisinin Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Dihydroartemisinin Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Dihydroartemisinin Players to Combat Covid-19 Impact
Table 11. Global Dihydroartemisinin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Dihydroartemisinin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Dihydroartemisinin Sales by Regions 2015-2020 (K MT)
Table 14. Global Dihydroartemisinin Sales Market Share by Regions (2015-2020)
Table 15. Global Dihydroartemisinin Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Dihydroartemisinin Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Dihydroartemisinin Sales Share by Manufacturers (2015-2020)
Table 18. Global Dihydroartemisinin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Dihydroartemisinin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dihydroartemisinin as of 2019)
Table 20. Dihydroartemisinin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Dihydroartemisinin Price (2015-2020) (USD/MT)
Table 23. Dihydroartemisinin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Dihydroartemisinin Product Type
Table 25. Date of International Manufacturers Enter into Dihydroartemisinin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 28. Global Dihydroartemisinin Sales Share by Type (2015-2020)
Table 29. Global Dihydroartemisinin Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Dihydroartemisinin Revenue Share by Type (2015-2020)
Table 31. Dihydroartemisinin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 33. Global Dihydroartemisinin Sales Share by Application (2015-2020)
Table 34. North America Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 35. North America Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 36. North America Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 38. North America Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 39. North America Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 40. North America Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 41. North America Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 42. Europe Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 43. Europe Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 44. Europe Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 46. Europe Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 47. Europe Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 48. Europe Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 49. Europe Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Dihydroartemisinin Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Dihydroartemisinin Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Dihydroartemisinin Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Dihydroartemisinin Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 58. Latin America Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 59. Latin America Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 62. Latin America Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 63. Latin America Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 64. Latin America Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 65. Latin America Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 74. Sanofi Corporation Information
Table 75. Sanofi Description and Major Businesses
Table 76. Sanofi Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi Product
Table 78. Sanofi Recent Development
Table 79. KPC Pharmaceuticals Corporation Information
Table 80. KPC Pharmaceuticals Description and Major Businesses
Table 81. KPC Pharmaceuticals Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. KPC Pharmaceuticals Product
Table 83. KPC Pharmaceuticals Recent Development
Table 84. Guangxi Xiancaotang Pharmaceutical Corporation Information
Table 85. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses
Table 86. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Guangxi Xiancaotang Pharmaceutical Product
Table 88. Guangxi Xiancaotang Pharmaceutical Recent Development
Table 89. Guilin Pharmaceutical Corporation Information
Table 90. Guilin Pharmaceutical Description and Major Businesses
Table 91. Guilin Pharmaceutical Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Guilin Pharmaceutical Product
Table 93. Guilin Pharmaceutical Recent Development
Table 94. Kerui Nanhai Pharmaceutical Corporation Information
Table 95. Kerui Nanhai Pharmaceutical Description and Major Businesses
Table 96. Kerui Nanhai Pharmaceutical Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Kerui Nanhai Pharmaceutical Product
Table 98. Kerui Nanhai Pharmaceutical Recent Development
Table 99. Shanghai Natural Bio-engineering Co Corporation Information
Table 100. Shanghai Natural Bio-engineering Co Description and Major Businesses
Table 101. Shanghai Natural Bio-engineering Co Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Shanghai Natural Bio-engineering Co Product
Table 103. Shanghai Natural Bio-engineering Co Recent Development
Table 104. Novanat Bioresource Corporation Information
Table 105. Novanat Bioresource Description and Major Businesses
Table 106. Novanat Bioresource Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Novanat Bioresource Product
Table 108. Novanat Bioresource Recent Development
Table 109. Botanical Extracts EPZ Ltd Corporation Information
Table 110. Botanical Extracts EPZ Ltd Description and Major Businesses
Table 111. Botanical Extracts EPZ Ltd Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Botanical Extracts EPZ Ltd Product
Table 113. Botanical Extracts EPZ Ltd Recent Development
Table 114. Global Dihydroartemisinin Sales Forecast by Regions (2021-2026) (K MT)
Table 115. Global Dihydroartemisinin Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Dihydroartemisinin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Dihydroartemisinin Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 119. North America: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 121. Europe: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Dihydroartemisinin Sales Forecast by Region (2021-2026) (K MT)
Table 123. Asia Pacific: Dihydroartemisinin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 125. Latin America: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 127. Middle East and Africa: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Dihydroartemisinin Players
Table 132. Dihydroartemisinin Customers List
Table 133. Dihydroartemisinin Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 1. Dihydroartemisinin Market Segments
Table 2. Ranking of Global Top Dihydroartemisinin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dihydroartemisinin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pharmaceutical Grade
Table 5. Major Manufacturers of Industrial Grade
Table 6. COVID-19 Impact Global Market: (Four Dihydroartemisinin Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Dihydroartemisinin Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Dihydroartemisinin Players to Combat Covid-19 Impact
Table 11. Global Dihydroartemisinin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Dihydroartemisinin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Dihydroartemisinin Sales by Regions 2015-2020 (K MT)
Table 14. Global Dihydroartemisinin Sales Market Share by Regions (2015-2020)
Table 15. Global Dihydroartemisinin Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Dihydroartemisinin Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Dihydroartemisinin Sales Share by Manufacturers (2015-2020)
Table 18. Global Dihydroartemisinin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Dihydroartemisinin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dihydroartemisinin as of 2019)
Table 20. Dihydroartemisinin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Dihydroartemisinin Price (2015-2020) (USD/MT)
Table 23. Dihydroartemisinin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Dihydroartemisinin Product Type
Table 25. Date of International Manufacturers Enter into Dihydroartemisinin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 28. Global Dihydroartemisinin Sales Share by Type (2015-2020)
Table 29. Global Dihydroartemisinin Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Dihydroartemisinin Revenue Share by Type (2015-2020)
Table 31. Dihydroartemisinin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 33. Global Dihydroartemisinin Sales Share by Application (2015-2020)
Table 34. North America Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 35. North America Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 36. North America Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 38. North America Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 39. North America Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 40. North America Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 41. North America Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 42. Europe Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 43. Europe Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 44. Europe Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 46. Europe Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 47. Europe Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 48. Europe Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 49. Europe Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Dihydroartemisinin Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Dihydroartemisinin Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Dihydroartemisinin Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Dihydroartemisinin Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 58. Latin America Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 59. Latin America Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 62. Latin America Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 63. Latin America Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 64. Latin America Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 65. Latin America Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Dihydroartemisinin Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Dihydroartemisinin Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Dihydroartemisinin Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Dihydroartemisinin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Dihydroartemisinin Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Dihydroartemisinin Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 74. Sanofi Corporation Information
Table 75. Sanofi Description and Major Businesses
Table 76. Sanofi Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi Product
Table 78. Sanofi Recent Development
Table 79. KPC Pharmaceuticals Corporation Information
Table 80. KPC Pharmaceuticals Description and Major Businesses
Table 81. KPC Pharmaceuticals Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. KPC Pharmaceuticals Product
Table 83. KPC Pharmaceuticals Recent Development
Table 84. Guangxi Xiancaotang Pharmaceutical Corporation Information
Table 85. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses
Table 86. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Guangxi Xiancaotang Pharmaceutical Product
Table 88. Guangxi Xiancaotang Pharmaceutical Recent Development
Table 89. Guilin Pharmaceutical Corporation Information
Table 90. Guilin Pharmaceutical Description and Major Businesses
Table 91. Guilin Pharmaceutical Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Guilin Pharmaceutical Product
Table 93. Guilin Pharmaceutical Recent Development
Table 94. Kerui Nanhai Pharmaceutical Corporation Information
Table 95. Kerui Nanhai Pharmaceutical Description and Major Businesses
Table 96. Kerui Nanhai Pharmaceutical Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Kerui Nanhai Pharmaceutical Product
Table 98. Kerui Nanhai Pharmaceutical Recent Development
Table 99. Shanghai Natural Bio-engineering Co Corporation Information
Table 100. Shanghai Natural Bio-engineering Co Description and Major Businesses
Table 101. Shanghai Natural Bio-engineering Co Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Shanghai Natural Bio-engineering Co Product
Table 103. Shanghai Natural Bio-engineering Co Recent Development
Table 104. Novanat Bioresource Corporation Information
Table 105. Novanat Bioresource Description and Major Businesses
Table 106. Novanat Bioresource Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Novanat Bioresource Product
Table 108. Novanat Bioresource Recent Development
Table 109. Botanical Extracts EPZ Ltd Corporation Information
Table 110. Botanical Extracts EPZ Ltd Description and Major Businesses
Table 111. Botanical Extracts EPZ Ltd Dihydroartemisinin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Botanical Extracts EPZ Ltd Product
Table 113. Botanical Extracts EPZ Ltd Recent Development
Table 114. Global Dihydroartemisinin Sales Forecast by Regions (2021-2026) (K MT)
Table 115. Global Dihydroartemisinin Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Dihydroartemisinin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Dihydroartemisinin Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 119. North America: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 121. Europe: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Dihydroartemisinin Sales Forecast by Region (2021-2026) (K MT)
Table 123. Asia Pacific: Dihydroartemisinin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 125. Latin America: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Dihydroartemisinin Sales Forecast by Country (2021-2026) (K MT)
Table 127. Middle East and Africa: Dihydroartemisinin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Dihydroartemisinin Players
Table 132. Dihydroartemisinin Customers List
Table 133. Dihydroartemisinin Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Dihydroartemisinin Product Picture
Figure 2. Global Dihydroartemisinin Sales Market Share by Type in 2020 & 2026
Figure 3. Pharmaceutical Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Global Dihydroartemisinin Sales Market Share by Application in 2020 & 2026
Figure 6. Malaria Treatment
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Dihydroartemisinin Report Years Considered
Figure 10. Global Dihydroartemisinin Market Size 2015-2026 (US$ Million)
Figure 11. Global Dihydroartemisinin Sales 2015-2026 (K MT)
Figure 12. Global Dihydroartemisinin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Dihydroartemisinin Sales Market Share by Region (2015-2020)
Figure 14. Global Dihydroartemisinin Sales Market Share by Region in 2019
Figure 15. Global Dihydroartemisinin Revenue Market Share by Region (2015-2020)
Figure 16. Global Dihydroartemisinin Revenue Market Share by Region in 2019
Figure 17. Global Dihydroartemisinin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Dihydroartemisinin Revenue in 2019
Figure 19. Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Dihydroartemisinin Sales Market Share by Type (2015-2020)
Figure 21. Global Dihydroartemisinin Sales Market Share by Type in 2019
Figure 22. Global Dihydroartemisinin Revenue Market Share by Type (2015-2020)
Figure 23. Global Dihydroartemisinin Revenue Market Share by Type in 2019
Figure 24. Global Dihydroartemisinin Market Share by Price Range (2015-2020)
Figure 25. Global Dihydroartemisinin Sales Market Share by Application (2015-2020)
Figure 26. Global Dihydroartemisinin Sales Market Share by Application in 2019
Figure 27. Global Dihydroartemisinin Revenue Market Share by Application (2015-2020)
Figure 28. Global Dihydroartemisinin Revenue Market Share by Application in 2019
Figure 29. North America Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Dihydroartemisinin Sales Market Share by Country in 2019
Figure 32. North America Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 33. U.S. Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Dihydroartemisinin Market Share by Type in 2019
Figure 38. North America Dihydroartemisinin Market Share by Application in 2019
Figure 39. Europe Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Dihydroartemisinin Sales Market Share by Country in 2019
Figure 42. Europe Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 43. Germany Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Dihydroartemisinin Market Share by Type in 2019
Figure 54. Europe Dihydroartemisinin Market Share by Application in 2019
Figure 55. Asia Pacific Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Dihydroartemisinin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Dihydroartemisinin Revenue Market Share by Region in 2019
Figure 59. China Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Dihydroartemisinin Market Share by Type in 2019
Figure 82. Asia Pacific Dihydroartemisinin Market Share by Application in 2019
Figure 83. Latin America Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Dihydroartemisinin Sales Market Share by Country in 2019
Figure 86. Latin America Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 87. Mexico Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Dihydroartemisinin Market Share by Type in 2019
Figure 94. Latin America Dihydroartemisinin Market Share by Application in 2019
Figure 95. Middle East and Africa Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Dihydroartemisinin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 99. Turkey Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Dihydroartemisinin Market Share by Type in 2019
Figure 106. Middle East and Africa Dihydroartemisinin Market Share by Application in 2019
Figure 107. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. KPC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Guangxi Xiancaotang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Kerui Nanhai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shanghai Natural Bio-engineering Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Novanat Bioresource Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Botanical Extracts EPZ Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. North America Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Europe Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Asia Pacific Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Latin America Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Middle East and Africa Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
Figure 1. Dihydroartemisinin Product Picture
Figure 2. Global Dihydroartemisinin Sales Market Share by Type in 2020 & 2026
Figure 3. Pharmaceutical Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Global Dihydroartemisinin Sales Market Share by Application in 2020 & 2026
Figure 6. Malaria Treatment
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Dihydroartemisinin Report Years Considered
Figure 10. Global Dihydroartemisinin Market Size 2015-2026 (US$ Million)
Figure 11. Global Dihydroartemisinin Sales 2015-2026 (K MT)
Figure 12. Global Dihydroartemisinin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Dihydroartemisinin Sales Market Share by Region (2015-2020)
Figure 14. Global Dihydroartemisinin Sales Market Share by Region in 2019
Figure 15. Global Dihydroartemisinin Revenue Market Share by Region (2015-2020)
Figure 16. Global Dihydroartemisinin Revenue Market Share by Region in 2019
Figure 17. Global Dihydroartemisinin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Dihydroartemisinin Revenue in 2019
Figure 19. Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Dihydroartemisinin Sales Market Share by Type (2015-2020)
Figure 21. Global Dihydroartemisinin Sales Market Share by Type in 2019
Figure 22. Global Dihydroartemisinin Revenue Market Share by Type (2015-2020)
Figure 23. Global Dihydroartemisinin Revenue Market Share by Type in 2019
Figure 24. Global Dihydroartemisinin Market Share by Price Range (2015-2020)
Figure 25. Global Dihydroartemisinin Sales Market Share by Application (2015-2020)
Figure 26. Global Dihydroartemisinin Sales Market Share by Application in 2019
Figure 27. Global Dihydroartemisinin Revenue Market Share by Application (2015-2020)
Figure 28. Global Dihydroartemisinin Revenue Market Share by Application in 2019
Figure 29. North America Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Dihydroartemisinin Sales Market Share by Country in 2019
Figure 32. North America Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 33. U.S. Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Dihydroartemisinin Market Share by Type in 2019
Figure 38. North America Dihydroartemisinin Market Share by Application in 2019
Figure 39. Europe Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Dihydroartemisinin Sales Market Share by Country in 2019
Figure 42. Europe Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 43. Germany Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Dihydroartemisinin Market Share by Type in 2019
Figure 54. Europe Dihydroartemisinin Market Share by Application in 2019
Figure 55. Asia Pacific Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Dihydroartemisinin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Dihydroartemisinin Revenue Market Share by Region in 2019
Figure 59. China Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Dihydroartemisinin Market Share by Type in 2019
Figure 82. Asia Pacific Dihydroartemisinin Market Share by Application in 2019
Figure 83. Latin America Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Dihydroartemisinin Sales Market Share by Country in 2019
Figure 86. Latin America Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 87. Mexico Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Dihydroartemisinin Market Share by Type in 2019
Figure 94. Latin America Dihydroartemisinin Market Share by Application in 2019
Figure 95. Middle East and Africa Dihydroartemisinin Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Dihydroartemisinin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Dihydroartemisinin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Dihydroartemisinin Revenue Market Share by Country in 2019
Figure 99. Turkey Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Dihydroartemisinin Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Dihydroartemisinin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Dihydroartemisinin Market Share by Type in 2019
Figure 106. Middle East and Africa Dihydroartemisinin Market Share by Application in 2019
Figure 107. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. KPC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Guangxi Xiancaotang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Kerui Nanhai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shanghai Natural Bio-engineering Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Novanat Bioresource Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Botanical Extracts EPZ Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. North America Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Europe Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Asia Pacific Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Latin America Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Dihydroartemisinin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Middle East and Africa Dihydroartemisinin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
